ImmunityBio

New Sign-Off Propels ImmunityBio – Los Angeles Business Journal

February 9, 2026 · Los Angeles, California Local News

Shares of Culver City-based immunotherapy company ImmunityBio Inc. had a huge runup in January, more than tripling in value to more than $7 a share on a pair…

ImmunityBio Wins U.K. Approval – Los Angeles Business Journal

August 18, 2025 · Los Angeles, California Local News

Culver City-based ImmunityBio Inc. has started to take its Anktiva immunotherapy drug global. Last month, the United Kingdom Medicines and Healthcare Products Regulatory Agency approved Anktiva for treatment…